A microRNA decreases the expression of the adhesion molecule CD44 in prostate cancer stem cells (CSCs), blocking tumor growth and metastasis in mice (pages 211–215). Systemic delivery of this negative regulator may open new avenues for targeting CSCs to halt cancer.
References
Wicha, M.S., Liu, S. & Dontu, G. Cancer Res. 66, 1883–1890 (2006).
Li, X. et al. J. Natl. Cancer Inst. 100, 672–679 (2008).
Lukacs, R.U. et al. Cell Stem Cell 7, 682–693 (2010).
Wang, X. et al. Nature 461, 495–500 (2009).
Tu, L.C. et al. Curr. Stem Cell Res. Ther. 4, 147–153 (2009).
Liu, C. et al. Nat. Med. 17, 211–215 (2011).
Grimson, A. et al. Mol. Cell 27, 91–105 (2007).
Zimmerman, A.L. & Wu, S. Cancer Lett. 300, 10–19 (2010).
Pacheco-Rodriguez, G. et al. Cancer Res. 67, 10573–10581 (2007).
Todaro, M. et al. Gastroenterology 138, 2151–2162 (2010).
Marangoni, E. et al. Br. J. Cancer 100, 918–922 (2009).
Jin, L. et al. Nat. Med. 12, 1167–1174 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.S.W. is a scientific advisor and holds equity in Oncomed Pharmaceuticals.
Rights and permissions
About this article
Cite this article
Wicha, M. Stemming a tumor with a little miR. Nat Med 17, 162–164 (2011). https://doi.org/10.1038/nm0211-162
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0211-162
- Springer Nature America, Inc.